M Privitera

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. ncbi Current challenges in the management of epilepsy
    Michael Privitera
    University of Cincinnati College of Medicine and Epilepsy Center at UC Neuroscience Institute, Cincinnati, OH 45267, USA
    Am J Manag Care 17:S195-203. 2011
  2. ncbi Detection of epileptogenic focal cortical dysplasia by depth, not subdural electrodes
    M D Privitera
    University of Cincinnati College of Medicine, Department of Neurology, OH 45267 0525, USA
    Neurosurg Rev 23:49-51. 2000
  3. ncbi Postictal language function
    Michael Privitera
    Department of Neurology, University of Cincinnati, Cincinnati, OH, USA
    Epilepsy Behav 19:140-5. 2010
  4. ncbi Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial
    Michael Privitera
    University of Cincinnati Medical Center 0525, 231 Albert B Sabin Way, Cincinnati, OH 45267 0525, USA
    Epilepsy Behav 5:841-6. 2004
  5. ncbi Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy
    M D Privitera
    Department of Neurology, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
    Acta Neurol Scand 107:165-75. 2003
  6. ncbi Efficacy of levetiracetam: a review of three pivotal clinical trials
    M Privitera
    University of Cincinnati Medical Center, Department of Neurology, Cincinnati, Ohio 45267 0525, USA
    Epilepsia 42:31-5. 2001
  7. ncbi Effects of breastfeeding in children of women taking antiepileptic drugs
    K J Meador
    Department of Neurology, Emory University, Woodruff Memorial Research Building, 101 Woodruff Circle, Suite 6000, Atlanta, GA 30322, USA
    Neurology 75:1954-60. 2010
  8. ncbi Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs
    Kimford J Meador
    Department of Neurology, Emory University, Woodruff Memorial Research Bldg, 101 Woodruff Cir, Suite 6000, Atlanta, GA 30322, USA
    N Engl J Med 360:1597-605. 2009
  9. ncbi Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine
    D M Ficker
    Department of Neurology, University of Cincinnati Medical Center, 231 Albert B Sabin Way, Cincinnati, OH 45267, USA
    Neurology 65:593-5. 2005
  10. ncbi Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence
    Jennifer Cavitt
    The Neuroscience Institute, Department of Neurology, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Arch Neurol 61:1604-7. 2004

Detail Information

Publications13

  1. ncbi Current challenges in the management of epilepsy
    Michael Privitera
    University of Cincinnati College of Medicine and Epilepsy Center at UC Neuroscience Institute, Cincinnati, OH 45267, USA
    Am J Manag Care 17:S195-203. 2011
    ..Patients with medication-resistant epilepsy may be candidates for epilepsy surgery, a highly effective treatment that is underutilized in this population...
  2. ncbi Detection of epileptogenic focal cortical dysplasia by depth, not subdural electrodes
    M D Privitera
    University of Cincinnati College of Medicine, Department of Neurology, OH 45267 0525, USA
    Neurosurg Rev 23:49-51. 2000
    ..We conclude that although subdural electrodes have many advantages when recording seizures outside the temporal lobes, depth electrodes may provide superior recordings when the epileptogenic region is beneath the cortical surface...
  3. ncbi Postictal language function
    Michael Privitera
    Department of Neurology, University of Cincinnati, Cincinnati, OH, USA
    Epilepsy Behav 19:140-5. 2010
    ..This highly cost-effective test provides important information on seizure localization and spread; is easily taught to technologists, nurses, and family members; and should be added to testing procedures in all epilepsy monitoring units...
  4. ncbi Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial
    Michael Privitera
    University of Cincinnati Medical Center 0525, 231 Albert B Sabin Way, Cincinnati, OH 45267 0525, USA
    Epilepsy Behav 5:841-6. 2004
    ..To identify appropriate instruments that could measure these factors, here we review several epilepsy-specific scales used to monitor adverse events and HRQOL and discuss their potential utility in the context of the proposed trial...
  5. ncbi Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy
    M D Privitera
    Department of Neurology, University of Cincinnati Medical Center, Cincinnati, OH 45267, USA
    Acta Neurol Scand 107:165-75. 2003
    ..To compare topiramate (TPM) with investigator's choice of carbamazepine (CBZ) or valproate (VPA) for initial treatment in patients with newly diagnosed epilepsy...
  6. ncbi Efficacy of levetiracetam: a review of three pivotal clinical trials
    M Privitera
    University of Cincinnati Medical Center, Department of Neurology, Cincinnati, Ohio 45267 0525, USA
    Epilepsia 42:31-5. 2001
    ..Levetiracetam was generally well tolerated in all studies. Results from these three pivotal studies demonstrate that levetiracetam, as adjunctive therapy, is a safe and effective treatment for refractory partial-onset seizures in adults...
  7. ncbi Effects of breastfeeding in children of women taking antiepileptic drugs
    K J Meador
    Department of Neurology, Emory University, Woodruff Memorial Research Building, 101 Woodruff Circle, Suite 6000, Atlanta, GA 30322, USA
    Neurology 75:1954-60. 2010
    ..Animal and human studies have demonstrated that some AEDs can adversely affect the immature brain. However, no investigation has examined effects of breastfeeding during AED therapy on subsequent cognitive abilities in children...
  8. ncbi Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs
    Kimford J Meador
    Department of Neurology, Emory University, Woodruff Memorial Research Bldg, 101 Woodruff Cir, Suite 6000, Atlanta, GA 30322, USA
    N Engl J Med 360:1597-605. 2009
    ....
  9. ncbi Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine
    D M Ficker
    Department of Neurology, University of Cincinnati Medical Center, 231 Albert B Sabin Way, Cincinnati, OH 45267, USA
    Neurology 65:593-5. 2005
    ..Using validated, epilepsy-specific measures the authors found that switching to CBZ-ERC significantly improved patients' adverse events and quality-of-life measures. Switching to CBZ-ERC also improved seizure control...
  10. ncbi Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence
    Jennifer Cavitt
    The Neuroscience Institute, Department of Neurology, University of Cincinnati, Cincinnati, Ohio 45267, USA
    Arch Neurol 61:1604-7. 2004
    ..Levetiracetam may be effective in generalized-onset epilepsy, and randomized, controlled trials are indicated...
  11. ncbi Antiepileptic drug use in women of childbearing age
    Kimford J Meador
    Department of Neurology, Emory University, Woodruff Memorial Research Building, 101 Woodruff Circle, Suite 6000, Mail Stop 1930 001 1AN, Atlanta, GA 30322, USA
    Epilepsy Behav 15:339-43. 2009
    ..Except for the top two AED monotherapies, there were marked differences in other monotherapies and in polytherapies between U.S. and UK centers. Future investigations are needed to examine reasons for drug choice...
  12. ncbi What does the family pictures subtest of the Wechsler Memory Scale-III measure? Insight gained from patients evaluated for epilepsy surgery
    Mario F Dulay
    Department of Psychology, University of Cincinnati, Cincinnati, OH 45221 0376, USA
    Clin Neuropsychol 16:452-62. 2002
    ..These results raise questions about the appropriateness of including FP task performance in the calculations of the WMS-III Visual Index scores...
  13. ncbi Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry
    Michael Privitera
    Epilepsy Res 68:52-6. 2006
    ....